Athira Gross Margin

The Gross Margin of Athira Pharma Inc (ATHA) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

Athira Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

Athira Gross Margin - Peers Comparison

Ticker	Name	Value
AMPE	Ampio Pharmaceuticals Inc	7775.20%
CRMD	CorMedix Inc	92.66%
PRTK	Paratek Pharmaceuticals Inc	85.61%
RDHL	Redhill Biopharma Ltd	60.31%
TFFP	TFF Pharmaceuticals Inc	7775.20%
WVE	WAVE Life Sciences Ltd	7775.20%
XERS	Xeris Biopharma Holdings Inc	81.86%
BMY	Bristol-Myers Squibb Co	75.26%
CTLT	Catalent Inc	21.75%
EYPT	EyePoint Pharmaceuticals Inc	91.42%
MRK	Merck & Co Inc	80.85%
ORMP	Oramed Pharmaceuticals Inc	100.00%
VYNE	Vyne Therapeutics Inc	93.38%
CBAY	CymaBay Therapeutics Inc	7775.20%
DRRX	DURECT Corp	96.16%
MMED.NE	Mind Medicine (MindMed) Inc	7775.20%
ZTS	Zoetis Inc	70.68%
ZYNE	Zynerba Pharmaceuticals Inc	7775.20%
KLDO	Kaleido Biosciences Inc	7775.20%
PFE	Pfizer Inc	74.33%
VTRS	Viatris Inc	41.65%
ELAN	Elanco Animal Health Inc	54.88%
EOLS	Evolus Inc	68.46%
FULC	Fulcrum Therapeutics Inc	7775.20%
ITRM	Iterum Therapeutics PLC	7775.20%
MIST	Milestone Pharmaceuticals Inc	7775.20%
RLMD	Relmada Therapeutics Inc	-
TARS	Tarsus Pharmaceuticals Inc	92.99%
CTXR	Citius Pharmaceuticals Inc	7775.20%
JNJ	Johnson & Johnson	69.11%
LLY	Eli Lilly and Co	81.31%
OMER	Omeros Corp	98.78%
PLXP	PLx Pharma Inc	41.46%
RPRX	Royalty Pharma PLC	7775.20%
SEEL	Seelos Therapeutics Inc	80.95%